Lysosomal Drug Sequestration Mediated by ABC Transporters and Drug Resistance
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F25%3A73633478" target="_blank" >RIV/61989592:15110/25:73633478 - isvavai.cz</a>
Result on the web
<a href="https://www.mdpi.com/1999-4923/17/10/1255" target="_blank" >https://www.mdpi.com/1999-4923/17/10/1255</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3390/pharmaceutics17101255" target="_blank" >10.3390/pharmaceutics17101255</a>
Alternative languages
Result language
angličtina
Original language name
Lysosomal Drug Sequestration Mediated by ABC Transporters and Drug Resistance
Original language description
Background: Drug resistance (DR) mediated by ABC transporters in the cytoplasmic membrane has been one of the best studied mechanisms of DR in vitro. More recently, it has also been suggested that ABC transporters expressed on lysosomal membranes could increase the sequestration of anticancer drugs in lysosomes, thereby reducing their concentration at target sites, and causing DR. Unfortunately, convincing evidence that such a DR mechanism actually exists is lacking, even in the case of in vitro experiments. Methods: This hypothetical study using simplified models evaluates the effect of ABC transporter-mediated accumulation of anticancer drugs in lysosomes on their concentration at target sites under standard in vitro conditions. Results: Calculations show that an ABC transporter resident on the plasma membrane must create and maintain a relatively small concentration gradient between extracellular space and the target site to reduce the drug concentration at the target site by, for example, half. In contrast, if a lysosomal ABC transporter is to also halve the concentration of the drug at the target site, then it must create and maintain a huge concentration gradient between lysosomes and target sites. It is very likely that massive accumulation of drugs in lysosomes would have a negative effect on the function of the lysosomes themselves. Conclusions: The results of this hypothetical study strongly suggest that the mechanism of DR mediated by lysosomal ABC transporters is questionable, as it requires enormous accumulation of the drug in lysosomes, which would likely also impair their function. Therefore, it is highly unlikely that this hypothetical DR mechanism could actually be utilized by tumor cells to defend against the cytotoxic effects of chemotherapy in vitro.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Pharmaceutics
ISSN
1999-4923
e-ISSN
—
Volume of the periodical
17
Issue of the periodical within the volume
10
Country of publishing house
CH - SWITZERLAND
Number of pages
14
Pages from-to
1255
UT code for WoS article
001601482900001
EID of the result in the Scopus database
2-s2.0-105020054313